Inventor
Peter Palese
Inventor
Leonia, NJ, US
Overview
Patents· 77 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes22%
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
Y02ATechnologies for adaptation to climate change8%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
C12YEnzymes3%
C07DHeterocyclic compounds1%
C07HSugars1%
PatentTitleYear
10,736,956Influenza virus vaccination regimens202010,583,188Influenza virus vaccines and uses thereof202010,544,207Antibodies against influenza virus hemagglutinin and uses thereof202010,543,268Genetically engineered swine influenza virus and uses thereof202010,308,913Chimeric viruses presenting non-native surface proteins and uses thereof201910,251,922Newcastle disease viruses and uses thereof201910,179,806Influenza virus vaccines and uses thereof201910,137,189Influenza virus vaccines and uses thereof201810,131,695Influenza virus vaccines and uses thereof201810,098,945Genetically engineered swine influenza virus and uses thereof201810,035,984Chimeric newcastle disease viruses and uses thereof20189,968,670Influenza virus vaccines and uses thereof20189,908,930'Antibodies against influenza virus hemagglutinin and uses thereof'20189,849,172Influenza virus vaccines and uses thereof20179,708,373'Influenza virus vaccine and uses thereof'20179,701,723'Vaccines for use in the prophylaxis and treatment of influenza virus disease'20179,549,975'Genetically engineered swine influenza virus and uses thereof'20179,387,242'Chimeric viruses presenting non-native surface proteins and uses thereof'20169,387,240'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals'20169,371,366'Influenza virus vaccines and uses thereof'20169,352,033'Methods for the propagation of modified influenza viruses in embryonated eggs'20169,238,815'Compositions and methods for inhibiting human host factors required for influenza virus replication'20169,217,157'Recombinant influenza viruses and uses thereof'20159,217,136'Chimeric Newcastle disease viruses and uses thereof'20159,175,069'Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof'20159,096,585'Antiviral compounds and uses thereof'20159,051,359'Influenza virus vaccines and uses thereof'20158,999,352'Genetically engineered swine influenza virus and uses thereof'20158,828,406'Influenza viruses and uses thereof'20148,765,139'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals'20148,709,442'Recombinant negative strand virus RNA expression systems and vaccines'20148,673,314'Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof'20148,629,283'Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof'20148,591,881'Chimeric Newcastle disease viruses and uses thereof'20138,137,676'Genetically engineered equine influenza virus and uses thereof'20128,124,101'Genetically engineered swine influenza virus and uses thereof'20128,057,803'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals'20118,012,490'Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents'20117,833,774'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents'20107,632,801'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication'20097,588,768'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals'20097,498,424'Nucleic acids encoding a novel influenza virus non-structural protein (NS1)-binding host factor designated NS1I-1'20097,494,808'Methods and interferon deficient substrates for the propagation of viruses'20097,442,527'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents'20087,442,379'Recombinant Newcastle disease virus RNA expression systems and vaccines'20087,384,774'Helper-free rescue of recombinant negative strand RNA virus'20087,276,356'Recombinant negative strand RNA virus expression systems and vaccines'20077,060,430'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents'20066,890,710'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication'20056,887,699'Recombinant negative strand RNA virus expression systems and vaccines'20056,884,414'Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents'20056,866,853'Interferon inducing genetically engineered attenuated viruses'20056,852,522'Methods and interferon deficient substrates for the propagation of viruses'20056,740,519'Immortalized, homozygous stat1-deficient mammalian cell lines and their uses'20046,669,943'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals'20036,649,372'Helper-free rescue of recombinant negative strand RNA virus'20036,635,416'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents'20036,573,079'Methods and interferon deficient substrates for the propagation of viruses'20036,544,785'Helper-free rescue of recombinant negative strand RNA viruses'20036,503,703'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication'20036,468,544'Interferon inducing genetically engineered attenuated viruses'20026,451,323'Recombinant newcastle disease virus RNA expression systems and vaccines'20026,316,243'Genetically engineered attenuated double-stranded RNA viruses'20016,150,131'Method for detecting antivirals that inhibit acylation/palmitylation of hemagglutinin'20006,146,642'Recombinant new castle disease virus RNA expression systems and vaccines'20006,022,726'Genetically engineered attenuated viruses'20006,001,634'Recombinant negative strand RNA viruses'19995,854,037'Recombinant negative strand RNA virus expression systems and vaccines'19985,840,520'Recombinant negative strand RNA virus expression systems'19985,820,871'Recombinant negative strand RNA virus expression systems and vaccines'19985,786,199'Recombinant negative strand RNA virus expression systems and vaccines'19985,750,394'Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication'19985,637,573'Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions'19975,578,473'Recombinant negative strand RNA virus'19965,194,428'Inhibition of influenza virus replication by oligonucleotide phosphorothioates'19935,166,057'Recombinant negative strand RNA virus expression-systems'19925,087,559'Method of detecting single base substitutions in nucleic acids'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2015Patents assigned to SINAI SCHOOL MEDICINE (34)· patent assignee history
1992–2017Based in Leonia, NJ, US· patent location history
2005Based in Leoma, NJ, US· patent location history
2005Based in Leonis, NJ, US· patent location history
2011–2017Patents assigned to GARCIA-SASTRE ADOLFO (18)· patent assignee history
2011–2017Patents assigned to PALESE PETER (18)· patent assignee history
2012–2020Patents assigned to US AGRICULTURE (5)· patent assignee history
2014–2020Patents assigned to ICAHN SCHOOL MED MOUNT SINAI (31)· patent assignee history
2014–2020Based in New York, NY, US· patent location history
2015Based in Loonta, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SINAI SCHOOL MEDICINE | 34 | 1992–2015 |
| ICAHN SCHOOL MED MOUNT SINAI | 31 | 2014–2020 |
| GARCIA-SASTRE ADOLFO | 18 | 2011–2017 |
| PALESE PETERself | 18 | 2011–2017 |
| US AGRICULTURE | 5 | 2012–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Leonia, New Jersey, US | 57 | 1992–2017 |
| New York, New York, US | 17 | 2014–2020 |
| Loonta, New Jersey, US | 1 | 2015 |
| Leoma, New Jersey, US | 1 | 2005 |
| Leonis, New Jersey, US | 1 | 2005 |